Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$200M |
| 2 |
Danaher
DHR
|
+$146M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$138M |
| 4 |
Procter & Gamble
PG
|
+$122M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.89B |
| 2 |
Microsoft
MSFT
|
+$380M |
| 3 |
Alibaba
BABA
|
+$352M |
| 4 |
Wells Fargo
WFC
|
+$245M |
| 5 |
American Electric Power
AEP
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.91% |
| 2 | Technology | 7.43% |
| 3 | Financials | 6.52% |
| 4 | Consumer Discretionary | 5.69% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HALL
3476
DELISTED
Hallmark Financial Services, Inc.
HALL
| $119K | ﹤0.01% |
2,946
-2,372
| -45% | -$321K |
|
|
PHK
3477
PIMCO High Income Fund
PHK
$848M
| $118K | ﹤0.01% |
24,170
-85,356
| -78% | -$581K |
|
|
ATNX
3478
DELISTED
Athenex, Inc. Common Stock
ATNX
| $118K | ﹤0.01% |
764
-38,415
| -98% | -$9.67M |
|
3479
Chemours
CC
$2.35B
| $116K | ﹤0.01% |
13,122
-25,283
| -66% | -$365K |
|
3480
CALL
Goodyear
GT
$1.73B
| $116K | ﹤0.01% |
+20,000
| New | +$218K |
|
|
VRS
3481
DELISTED
Verso Corporation
VRS
| $116K | ﹤0.01% |
+10,267
| New | +$160K |
|
3482
Amkor Technology
AMKR
$12.2B
| $115K | ﹤0.01% |
14,717
-614,206
| -98% | -$6.68M |
|
3483
BCB Bancorp
BCBP
$157M
| $115K | ﹤0.01% |
+10,815
| New | +$133K |
|
|
GREK
3484
Global X MSCI Greece ETF
GREK
$343M
| $115K | ﹤0.01% |
6,710
-32,608
| -83% | -$806K |
|
3485
Ultralife
ULBI
$112M
| $115K | ﹤0.01% |
22,129
+4,917
| +29% | +$33.6K |
|
|
BXRX
3486
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
| $115K | ﹤0.01% |
33
-79
| -71% | -$746K |
|
|
WPX
3487
DELISTED
WPX Energy, Inc.
WPX
| $115K | ﹤0.01% |
37,681
-9,383,392
| -100% | -$88.5M |
|
3488
Fennec Pharmaceuticals
FENC
$411M
| $114K | ﹤0.01% |
+19,180
| New | +$125K |
|
3489
Revolve Group
RVLV
$1.65B
| $114K | ﹤0.01% |
+13,151
| New | +$209K |
|
3490
Spero Therapeutics
SPRO
$71.6M
| $114K | ﹤0.01% |
14,055
+1,373
| +11% | +$12.1K |
|
3491
PUT
Freeport-McMoran
FCX
$113B
| $113K | ﹤0.01% |
+16,800
| New | +$176K |
|
|
GSV
3492
DELISTED
Gold Standard Ventures Corp.
GSV
| $113K | ﹤0.01% |
225,918
+60,508
| +37% | +$40.1K |
|
3493
CarParts.com
PRTS
$49.4M
| $111K | ﹤0.01% |
+6,358
| New | +$154K |
|
|
RYZ
3494
Ryerson Holding Corp
RYZ
$1.27B
| $111K | ﹤0.01% |
20,933
-114,515
| -85% | -$1.01M |
|
|
BCOW
3495
DELISTED
1895 Bancorp of Wisconsin
BCOW
| $109K | ﹤0.01% |
18,325
+255
| +1% | +$2.01K |
|
|
SLCT
3496
DELISTED
Select Bancorp, Inc.
SLCT
| $108K | ﹤0.01% |
14,162
-37,345
| -73% | -$393K |
|
|
UNT
3497
DELISTED
UNIT Corporation
UNT
| $106K | ﹤0.01% |
406,567
-1,544,652
| -79% | -$584K |
|
3498
APA Corp
APA
$14.6B
| $105K | ﹤0.01% |
25,025
-456,696
| -95% | -$10.2M |
|
3499
Genprex
GNPX
$3.3M
| $105K | ﹤0.01% |
+1
| New | +$103K |
|
3500
BioCardia
BCDA
$16.5M
| $104K | ﹤0.01% |
2,145
-2
| -0.1% | -$124 |
|
Similar funds
Israel Englander's Q1 2020 Portfolio in Review
As of Q1 2020, Israel Englander held 4,928 positions worth $44.5B, down 44% from $79.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander withdrew a net $21.4B in Q1 2020, closing 1,154 positions and reducing 1,745 holdings. Its most notable exit was Becton Dickinson, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 10% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Danaher worth $133M.
- Israel Englander's largest Q1 2020 buy was Danaher: 1,082,448 shares worth $133M.
- Israel Englander added most to Allergan plc in Q1 2020, an estimated $200M increase.
- Israel Englander's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.89B.
- Israel Englander fully exited Becton Dickinson in Q1 2020, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 18% of its $44.5B portfolio in Q1 2020.
- Israel Englander opened 789 new positions and closed 1,154 in Q1 2020.
- Israel Englander's portfolio value fell 44% quarter-over-quarter to $44.5B.
Based on Millennium Management's 13F filing for Q1 2020, filed 14 May 2020.